European Medicines Agency publishes Brexit guidance for pharma companies
The European Medicines Agency has published additional guidance for pharmaceutical companies to help them prepare for the United Kingdom’s withdrawal from the European Union.
Related articles
-
ArticleDigital wallets should speed up compliance, but companies must focus on trust and security
The EU has one, the U.K. is getting one, many U.S. states are working with Google and Apple to provide one, and now industry sectors are developing their own digital wallet.
-
PremiumCompliance in the spotlight as tariffs, sanctions turn into geopolitical weapons
Navigating tariffs and sanctions is becoming a core part of compliance for many companies. As the U.S. and others use economic policies for political aims, compliance teams must adapt to this new geoeconomic trend.
-
ArticleU.K. hopes to create ‘third way’ in AI regulation between EU and U.S.
The U.K.’s data regulator has unveiled a new enforcement approach to AI development and usage that experts say seeks to carve a middle way between the strict rules applied by the European Union (EU) and the pro-industry, light-touch regime favored by the U.S.